Florian Lordick
MD
Professor of Oncology, Director of University Cancer Center
👥Biography 个人简介
Florian Lordick at the University of Leipzig has been central to European gastric cancer research including work on CLDN18.2 as a therapeutic target. He was involved in the SPOTLIGHT and GLOW trials that established zolbetuximab plus chemotherapy as a new standard for CLDN18.2-positive HER2-negative advanced gastric cancer. His research has contributed to the molecular characterization of gastric cancer and the identification of actionable targets beyond HER2. He has led ESMO and German AIO clinical guideline development for gastric cancer and has been a key figure in European GI oncology.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Florian Lordick 的研究动态
Follow Florian Lordick's research updates
留下邮箱，当我们发布与 Florian Lordick（University of Leipzig）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment